Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.
The new title recognizes the increasing leadership roles Self is playing in several important institutional initiatives, including the Clinical and Translational Science Award (CTSA) and the Trial Innovation Center (TIC). He is also principal investigator of the IVY Network funded by the Centers for Disease Control and Prevention (CDC) to study viral respiratory infections in critical illness, co-principal Investigator for the PassItOn trial of convalescent plasma funded by the National Center for Advancing Translational Sciences (NCATS), and a leader in the Administrative Coordinating Center for COVID-19 trials funded by the National Heart, Lung and Blood Institute (NHLBI).